Medical System Network Co 4350.T · JPY

Its shares trade on Tokyo Stock Exchange under the ticker 4350.T. It has been listed since 12 September 2008. In the fiscal year to 31 March 2026, it reported revenue of ¥132.19bn and net income of ¥1.07bn. At that date it held total assets of ¥80.10bn and shareholders' equity of ¥17.29bn.

Medical System Network Co., Ltd. engages in the pharmaceuticals network business. The company is headquartered in Sapporo, Hokkaido. The company went IPO on 2008-09-12. The firm operates in five business segments. The Pharmaceutical Product Network segment involves in ordering system of medicines, development and sale of systems, and support services for securitized receivables. The Dispensing Pharmacy segment operates and manages dispensing pharmacies. The Leasing and Equipment-related Business segment involves in the location development of pharmacies, the rental of buildings for clinics, and the operation of buildings and housing for the elderly. The Food Supply segments provides food service within hospitals and welfare facilities. The Others segment involves in clinical trial support services and visiting nursing services.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Inao TajiriPresident, Chairman of Subsidiary, Representative Director, since 1999
• Mr. Eiji HirashimaManaging Executive Officer, Chief Director of Accounting and Finance, Director, since 1999
• Mr. Jiro AkinoVice President, Representative Director, since 1999
• Mr. Yoshihiro TanakaVice President, Representative Director, since 2006
• Mr. Makoto SakashitaSenior Managing Executive Officer, Chief Director of Administration, Chief Director of Medical Welfare Support, Director, since 2008
• Mr. Akira AoyamaManaging Executive Officer, Chief Director of System, Director, since 2013
• Mr. Kazuhiko SumiManaging Executive Officer, Director, since 2000
• Mr. Kenji ShimizuExecutive Officer, Chief Director of SCM Business, Director, since 2020
• Mr. Kentaro TagoExecutive Officer, Chief Director of Business Strategy, President of Subsidiary, Representative Director, since 2016
• Mr. Shuichi NakamuraDirector
• Ms. Toshiko IbeIndependent Director
• Mr. Kozo IsshikiIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.